Kintara Therapeutics (KTRA) News Today → The only AI company to buy (From Porter & Company) (Ad) Free KTRA Stock Alerts $0.19 +0.02 (+13.10%) (As of 03:10 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14, 2024 | prnewswire.comKintara Therapeutics Announces Fiscal 2024 Third Quarter Financial ResultsMay 3, 2024 | nasdaq.comKintara Therapeutics, Inc. Common Stock (KTRA)April 11, 2024 | stockhouse.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVLY, CTLT, SCX, KTRAApril 10, 2024 | stockhouse.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MODN, KTRAApril 9, 2024 | prnewswire.comSTOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Kintara Biopharma, Inc. - KTRAApril 5, 2024 | businesswire.comKINTARA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Kintara Therapeutics, Inc. - KTRAApril 5, 2024 | finance.yahoo.comAPhA and CDC select Community of Practice Teams to advance health equity and prevent heart disease and strokeApril 3, 2024 | markets.businessinsider.comCrude Oil Moves Higher; ISM Services PMI Falls In MarchApril 3, 2024 | msn.comWhy Kintara Therapeutics Shares Are Gaining TodayApril 3, 2024 | stockhouse.comKTRA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Kintara Therapeutics, Inc. Is Fair to ShareholdersApril 3, 2024 | prnewswire.comShareholder Alert: Ademi LLP investigates whether Kintara Therapeutics, Inc. has obtained a Fair Price in its transaction with TuHURAApril 3, 2024 | investorplace.comWhy Is Kintara Therapeutics (KTRA) Stock Up 103% Today?April 3, 2024 | marketwatch.comKintara Therapeutics Sets Reverse Merger With TuHURA BiosciencesApril 3, 2024 | markets.businessinsider.comKintara Therapeutics To Merge Into TuHURA BiosciencesApril 3, 2024 | finance.yahoo.comKintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger AgreementApril 3, 2024 | marketbeat.comTrading was temporarily halted for "KTRA" at 06:04 AM with a stated reason of "News pending."March 27, 2024 | finance.yahoo.comKintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on PembrolizumabMarch 27, 2024 | prnewswire.comKintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on PembrolizumabMarch 15, 2024 | nasdaq.comKintara Therapeutics Bounces BackFebruary 21, 2024 | uk.investing.comKintara Therapeutics Inc (KTRA)February 20, 2024 | uk.investing.comMyMD Pharmaceuticals Inc (0A8D)February 14, 2024 | finance.yahoo.comKintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate UpdateFebruary 14, 2024 | prnewswire.comKintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate UpdateFebruary 12, 2024 | finance.yahoo.comKintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast CancerFebruary 1, 2024 | msn.comPanbela Therapeutics closes ~$9M public offering of sharesDecember 7, 2023 | markets.businessinsider.comKintara Announces Review Of Strategic Alternatives To Maximize Stockholder ValueDecember 7, 2023 | finance.yahoo.comKintara Therapeutics Announces Review of Strategic AlternativesNovember 28, 2023 | ca.finance.yahoo.comKintara Therapeutics Inc (3DMA.BE)November 16, 2023 | morningstar.comKintara Therapeutics Inc KTRANovember 13, 2023 | finance.yahoo.comKintara Therapeutics Announces Fiscal 2024 First Quarter Financial Results and Provides Corporate UpdateNovember 1, 2023 | benzinga.comWhy Kintara Therapeutics (KTRA) Shares Are Getting ObliteratedOctober 31, 2023 | marketwatch.comKintara Therapeutics Shares Plumb New Depths on VAL-083 FailureOctober 31, 2023 | marketbeat.comTrading was temporarily halted for "KTRA" at 09:10 AM with a stated reason of "LULD pause."October 31, 2023 | marketwatch.comKintara Says Glioblastoma Treatment Candidate Shows Little PromiseOctober 31, 2023 | marketwatch.comKintara Shares Down 72% After Suspending Glioblastoma Drug DevelopmentOctober 31, 2023 | markets.businessinsider.comKintara Therapeutics Suspends Development Of VAL-083 In Glioblastoma; Stock DropsOctober 31, 2023 | marketbeat.comTrading was temporarily halted for "KTRA" at 07:10 AM with a stated reason of "News pending."October 26, 2023 | marketbeat.comTrading was temporarily halted for "KTRA" at 09:10 AM with a stated reason of "LULD pause." Trading set to resume at 09:10 AM. October 11, 2023 | finance.yahoo.comKintara Therapeutics to Present at the 8th Annual Dawson James Small Cap Growth ConferenceOctober 2, 2023 | finance.yahoo.comKintara Therapeutics to Present at the LD Micro Main Event XVI ConferenceSeptember 25, 2023 | finance.yahoo.comKintara Therapeutics Presents Case Studies of Glioblastoma Patients Treated with VAL-083 at 2023 European Association for Neuro-Oncology Annual MeetingSeptember 19, 2023 | seekingalpha.comKintara Therapeutics Non-GAAP EPS of -$9.27September 18, 2023 | finance.yahoo.comKintara Therapeutics Announces Fiscal 2023 Year Financial Results and Provides Corporate UpdateSeptember 14, 2023 | uk.finance.yahoo.comKTRA - Kintara Therapeutics, Inc.September 5, 2023 | finance.yahoo.comKintara Therapeutics to Present at the 2023 European Association for Neuro-Oncology Annual MeetingAugust 17, 2023 | finance.yahoo.comKintara Therapeutics to Host Virtual KOL Event on VAL-083, A Potential First-in-Class Small Molecule Chemotherapeutic for Glioblastoma, on August 21, 2023August 9, 2023 | finance.yahoo.comKintara Therapeutics to Present at the Emerging Growth ConferenceAugust 8, 2023 | finance.yahoo.comPresenting on the Emerging Growth Conference on August 9 & 10 Register NowJuly 14, 2023 | msn.comBenzinga's Top Ratings Upgrades, Downgrades For July 14, 2023June 30, 2023 | finance.yahoo.comKintara (KTRA) Rises 41% on $2M Grant for Breast Cancer Therapy Get Kintara Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KTRA and its competitors with MarketBeat's FREE daily newsletter. Email Address The only AI company to buy (Ad)The AI boom is just getting started. And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. KTRA Media Mentions By Week KTRA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KTRA News Sentiment▼1.880.92▲Average Medical News Sentiment KTRA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KTRA Articles This Week▼31▲KTRA Articles Average Week Get Kintara Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KTRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AEZS News Today GRTX News Today VAXX News Today MTEM News Today NCNA News Today MNPR News Today UPC News Today ADXN News Today ATHE News Today CMMB News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KTRA) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersThe 7th Trillion Dollar Company?The Oxford ClubThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarElon to Transform U.S. Economy? Porter & CompanyBiden replacement revealed?Paradigm Press[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaDigitizing the $11T commodities sector with one tiny stockResource Stock DigestTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesWARNING about the death of the U.S. dollar…Colonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kintara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
